Efficacy, Immunogenicity, and Safety Study of a Respiratory Syncytial Virus Vaccine in Infants and Toddlers

Clinical trial NCT06252285 · TERMINATED

Trial details

NCT number: NCT06252285
Sponsor: Sanofi Pasteur, a Sanofi Company
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

RSV Immunisation

Start date: 2024-02-06
Primary completion: 2025-12-04
Enrollment: 6300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.